Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Improving Diabetic Foot Ulcers With Atorvastatin

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00134550
Recruitment Status : Completed
First Posted : August 25, 2005
Last Update Posted : September 23, 2009
Sponsor:
Collaborator:
Pfizer
Information provided by:
Asker & Baerum Hospital

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : March 2007
Actual Study Completion Date : March 2007
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 November 16, 2009
December 16, 2009
2 May 24, 2010
June 18, 2010
3 January 23, 2017
March 14, 2017
Publications of Results:
Healing of diabetic foot ulcers may be modified by high dose atorvastatin - a 6 month randomised controlled pilot trial European Association for the Study of Diabetes 2008 Johansen OE, Birkeland KI, Jørgensen AP, Orvik E, Sørgård B, Torjussen BR, Ueland T, Aukrust P, Gullestad L Diabetologia 2008;51(S1):S515.